Company Search:
Advanced Search
Sponsored Links
Merus NV Company Snapshot
Merus NV operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Merus NV with three other companies in this sector in UNITED STATES : Frequency Therapeutics Inc (2019 sales of $28.95 million of which 100% was Small molecules), Zymeworks Inc ($29.54 million of which 100% was Pharmaceutical), and Nurix Therapeutics Inc ($31.12 million of which 100% was PHARMACEUTICAL PREPARATIONS).

Sales Analysis. During the year ended December of 2019, sales at Merus NV were $31.13 million. This is a decrease of 16.0% versus 2018, when the company's sales were $37.05 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Merus NV
  Stock Performance Chart for Merus NV
  Stock Data: Recent Stock Performance:
  Current Price (3/5/2021): 22.74
(Figures in U.S. Dollars)
1 Week 1.1%   13 Weeks -12.5%  
4 Weeks 33.4%   52 Weeks 30.8%  
Merus NV Key Data:
  Ticker: MRUS Country: Netherlands
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 31,133,000
(Year Ending Jan 2020).
Employees: 132
  Currency: U.S. Dollars Market Cap: 661,154,949
  Fiscal Yr Ends: December Shares Outstanding: 29,074,536
  Share Type: Common Closely Held Shares: 3,242,011
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.